[86] described that RG7834, a novel oral HBV gene expression inhibitor, could lessen the levels of viral proteins and decrease viremia. RG7834 is a small-molecule compound belonging to the dihydroquinolizinones chemical course much like RNAi but by means of a different system. Furthermore, this process could inactivate the mutation of https://scottu742kot5.wikiexcerpt.com/user